Literature DB >> 30069350

Surgery for hemoptysis in patients with benign lung disease.

Ju Sik Yun1, Sang Yun Song1, Kook Joo Na1, Seok Kim1, Keun-Ho Jang2, In Seok Jeong3, Sang Gi Oh3.   

Abstract

BACKGROUND: Hemoptysis can be a life-threatening condition that requires urgent treatment. Surgery still plays an important role in managing this critical situation, although previous reports have reported high postoperative morbidity and mortality rates. We report our experience with surgical resection for hemoptysis caused by benign lung diseases.
METHODS: We reviewed the retrospectively collected data from 94 patients undergoing pulmonary resection for various benign lung diseases with hemoptysis at a single institution from 2010 to 2016. Baseline characteristics, surgical factors, and postoperative outcomes (morbidity and mortality rates) were analyzed.
RESULTS: The ratio of male to female patients was 1:1, and the mean age was 58.2±11.1 (range, 29-79) years. The etiology of hemoptysis included aspergilloma in 58 patients (61.7%), bronchiectasis in 10, tuberculosis in 7, necrotizing bronchiolitis in 6, and other inflammatory disease in 13. A total of 21 patients (22.3%) underwent emergency operation, and 73 (77.7%) had an elective operation. Pulmonary resection was performed by thoracotomy (n=53, 56.4%) and video-assisted thoracoscopic surgery (VATS) (n=41, 43.6%). Sublobar resection (n=50, 53.2%, segmentectomy in 19 and wedge resection in 31) was performed more often than lobectomy (n=35, 37.2%). Pneumonectomy was performed in 7 patients, and bilobectomy was performed in 2. Postoperative morbidity occurred in 23 patients (24.5%), with prolonged air leak being the most frequent complication (n=14, 14.9%). The in-hospital mortality rate was 3.2% (n=3). Complications were less frequent in patients undergoing an elective operation, VATS, and sublobar resection. Multivariate analysis showed that patients treated with VATS had a decreased risk of postoperative complications (odds ratio, 12.8; 95% confidence interval, 1.29-127.9; P=0.03).
CONCLUSIONS: Surgical resection for hemoptysis in patients with benign lung diseases is the mainstay of effective treatment with acceptable morbidity and mortality rates. If applicable, we recommend elective (planned) sublobar resection using VATS in order to improve postoperative outcomes.

Entities:  

Keywords:  Surgery; benign lung disease; hemoptysis

Year:  2018        PMID: 30069350      PMCID: PMC6051871          DOI: 10.21037/jtd.2018.05.122

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  29 in total

Review 1.  Massive hemoptysis: an update on the role of bronchoscopy in diagnosis and management.

Authors:  L Sakr; H Dutau
Journal:  Respiration       Date:  2010-01-08       Impact factor: 3.580

2.  Surgical lung resection for severe hemoptysis.

Authors:  Claire Andréjak; Antoine Parrot; Bernard Bazelly; Pierre Yves Ancel; Michel Djibré; Antoine Khalil; Dominique Grunenwald; Muriel Fartoukh
Journal:  Ann Thorac Surg       Date:  2009-11       Impact factor: 4.330

3.  Management and prognosis of massive hemoptysis. Recent experience with 120 patients.

Authors:  C J Knott-Craig; J G Oostuizen; G Rossouw; J R Joubert; P M Barnard
Journal:  J Thorac Cardiovasc Surg       Date:  1993-03       Impact factor: 5.209

4.  Surgery for hemoptysis in various pulmonary tuberculous lesions: a prospective study.

Authors:  Alaa Brik; Abdel-Maged Salem; Amira Shoukry; Waheed Shouman
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-06-16

5.  Bronchial artery embolization for hemoptysis due to benign diseases: immediate and long-term results.

Authors:  A Kato; S Kudo; K Matsumoto; T Fukahori; T Shimizu; A Uchino; S Hayashi
Journal:  Cardiovasc Intervent Radiol       Date:  2000 Sep-Oct       Impact factor: 2.740

6.  Surgical treatment for pulmonary tuberculosis: is video-assisted thoracic surgery "better" than thoracotomy?

Authors:  Yi Han; Dezhi Zhen; Zhidong Liu; Shaofa Xu; Shuku Liu; Ming Qin; Shijie Zhou; Daping Yu; Xiaoyun Song; Yunsong Li; Ning Xiao; Chongyu Su; Kang Shi
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

7.  Surgery of massive hemoptysis in pulmonary tuberculosis: immediate and long-term outcomes.

Authors:  Yi Zhang; Chang Chen; Ge-ning Jiang
Journal:  J Thorac Cardiovasc Surg       Date:  2014-01-15       Impact factor: 5.209

8.  Prevalence and outcomes of anatomic lung resection for hemoptysis: an analysis of the nationwide inpatient sample database.

Authors:  Subroto Paul; Weston Andrews; Abu Nasar; Jeffrey L Port; Paul C Lee; Brendon M Stiles; Art Sedrakyan; Nasser K Altorki
Journal:  Ann Thorac Surg       Date:  2013-06-28       Impact factor: 4.330

Review 9.  Thoracic surgery for haemoptysis in the context of tuberculosis: what is the best management approach?

Authors:  Semih Halezeroğlu; Erdal Okur
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

10.  Pulmonary resection for massive hemoptysis of benign etiology.

Authors:  Adel Ayed
Journal:  Eur J Cardiothorac Surg       Date:  2003-11       Impact factor: 4.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.